Berenberg Bank reissued their buy rating on shares of Smith & Nephew (NYSE:SNN) in a report issued on Friday morning, The Fly reports.

Several other equities research analysts have also recently commented on SNN. BNP Paribas cut Smith & Nephew from a neutral rating to an underperform rating in a report on Friday, June 5th. Citigroup cut Smith & Nephew from a buy rating to a neutral rating in a report on Tuesday, April 14th. Cfra cut their target price on Smith & Nephew from $52.00 to $42.00 and set a hold rating for the company in a research note on Thursday, May 7th. Zacks Investment Research raised Smith & Nephew from a sell rating to a hold rating in a research note on Tuesday, June 2nd. Finally, JPMorgan Chase & Co. reissued a neutral rating on shares of Smith & Nephew in a research note on Thursday, May 7th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company. Smith & Nephew presently has a consensus rating of Hold and an average price target of $48.00.

NYSE:SNN opened at $38.51 on Friday. Smith & Nephew has a one year low of $26.07 and a one year high of $52.26. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 2.06. The stock has a market cap of $16.86 billion, a PE ratio of 18.88, a P/E/G ratio of 6.20 and a beta of 0.56. The stock has a 50 day moving average price of $40.45 and a 200 day moving average price of $42.21.

Several hedge funds and other institutional investors have recently modified their holdings of SNN. WCM Investment Management LLC grew its stake in shares of Smith & Nephew by 57.0% in the first quarter. WCM Investment Management LLC now owns 6,585,160 shares of the medical equipment provider’s stock valued at $236,210,000 after buying an additional 2,389,692 shares in the last quarter. BlackRock Inc. grew its stake in shares of Smith & Nephew by 18,404.8% in the first quarter. BlackRock Inc. now owns 1,370,283 shares of the medical equipment provider’s stock valued at $49,152,000 after buying an additional 1,362,878 shares in the last quarter. FMR LLC grew its stake in shares of Smith & Nephew by 640.8% in the first quarter. FMR LLC now owns 1,341,034 shares of the medical equipment provider’s stock valued at $53,788,000 after buying an additional 1,160,015 shares in the last quarter. Nuance Investments LLC grew its stake in shares of Smith & Nephew by 22.8% in the first quarter. Nuance Investments LLC now owns 4,075,928 shares of the medical equipment provider’s stock valued at $146,204,000 after buying an additional 757,972 shares in the last quarter. Finally, Royal Bank of Canada grew its stake in shares of Smith & Nephew by 101.6% in the first quarter. Royal Bank of Canada now owns 720,405 shares of the medical equipment provider’s stock valued at $25,841,000 after buying an additional 363,007 shares in the last quarter. 9.40% of the stock is owned by institutional investors and hedge funds.

Smith & Nephew Company Profile

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Featured Story: What are the reasons investors use put options?

The Fly

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.